$2.34 Billion is the total value of Tekla Capital Management LLC's 203 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 19.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JNJ | Buy | Johnson & Johnson | $133,261,000 | -3.3% | 1,032,628 | +3.6% | 5.70% | +14.2% |
| BIIB | Buy | Biogen Inc. | $118,834,000 | -14.1% | 394,902 | +0.9% | 5.09% | +1.4% |
| UNH | Buy | Unitedhealth Group Incorporated | $93,513,000 | +2.0% | 375,374 | +9.0% | 4.00% | +20.4% |
| CELG | Buy | Celgene Corporation | $88,573,000 | -24.6% | 1,382,006 | +5.3% | 3.79% | -11.0% |
| ILMN | Buy | Illumina, Inc. | $78,695,000 | -11.7% | 262,379 | +8.1% | 3.37% | +4.3% |
| VRTX | Buy | Vertex Pharmaceuticals Incorporated | $70,634,000 | -10.2% | 426,248 | +4.4% | 3.02% | +5.9% |
| PFE | Buy | Pfizer Inc. | $66,208,000 | +10.9% | 1,516,793 | +12.0% | 2.83% | +31.0% |
| MRK | Buy | Merck & Co., Inc. | $56,399,000 | +23.2% | 738,108 | +14.4% | 2.41% | +45.4% |
| ALXN | Buy | Alexion Pharmaceuticals, Inc. | $48,319,000 | -20.7% | 496,288 | +13.2% | 2.07% | -6.4% |
| MDT | Buy | Medtronic plcshares | $43,785,000 | +31.1% | 481,365 | +41.8% | 1.87% | +54.7% |
| TMO | Buy | Thermo Fisher Scientific Inc. | $42,944,000 | -2.5% | 191,895 | +6.4% | 1.84% | +15.1% |
| BMY | Buy | Bristol-Myers Squibb Company | $33,941,000 | +49.4% | 652,966 | +78.4% | 1.45% | +76.3% |
| CVS | Buy | CVS Health Corporation | $30,185,000 | -4.4% | 460,698 | +14.9% | 1.29% | +12.8% |
| ZTS | Buy | Zoetis Inc.class a | $21,506,000 | +3.3% | 251,415 | +10.6% | 0.92% | +22.0% |
| ISRG | Buy | Intuitive Surgical, Inc. | $18,788,000 | +32.9% | 39,229 | +59.3% | 0.80% | +56.7% |
| TEVA | Buy | Teva Pharmaceutical Industries Limitedsponsored adr | $18,687,000 | -7.0% | 1,211,868 | +29.9% | 0.80% | +9.7% |
| BMRN | Buy | BioMarin Pharmaceutical Inc. | $17,663,000 | +29.6% | 207,434 | +47.6% | 0.76% | +53.0% |
| BDX | Buy | Becton, Dickinson and Company | $15,722,000 | -6.1% | 69,778 | +8.7% | 0.67% | +10.9% |
| NBIX | Buy | Neurocrine Biosciences, Inc. | $15,446,000 | -40.9% | 216,294 | +1.7% | 0.66% | -30.3% |
| JAZZ | Buy | Jazz Pharmaceuticals plcshares | $14,279,000 | -23.1% | 115,187 | +4.3% | 0.61% | -9.2% |
| CI | New | Cigna Corporation | $12,172,000 | – | 64,089 | +100.0% | 0.52% | – |
| BAX | Buy | Baxter International Inc. | $10,612,000 | -5.7% | 161,233 | +10.4% | 0.45% | +11.3% |
| XBI | Buy | SPDR S&P Biotech ETFs&p biotech etf | $10,362,000 | -16.2% | 144,424 | +12.0% | 0.44% | -1.1% |
| FGEN | Buy | FibroGen, Inc. | $9,847,000 | -9.0% | 212,763 | +19.4% | 0.42% | +7.1% |
| BLUE | Buy | bluebird bio, Inc. | $9,764,000 | -23.8% | 98,429 | +12.1% | 0.42% | -10.1% |
| MDCO | Buy | The Medicines Company | $8,211,000 | +65.5% | 428,992 | +158.7% | 0.35% | +95.0% |
| DPLO | Buy | Diplomat Pharmacy, Inc. | $6,807,000 | -20.1% | 505,701 | +15.2% | 0.29% | -5.8% |
| PRAH | Buy | PRA Health Sciences, Inc. | $6,480,000 | +81.2% | 70,460 | +117.1% | 0.28% | +113.1% |
| ALGN | Buy | Align Technology, Inc. | $6,254,000 | +42.2% | 29,860 | +165.6% | 0.27% | +67.5% |
| GWPH | Buy | GW Pharmaceuticals plcads | $6,169,000 | -18.1% | 63,345 | +45.3% | 0.26% | -3.3% |
| IMMU | Buy | Immunomedics, Inc. | $6,158,000 | +203.6% | 431,527 | +343.2% | 0.26% | +256.8% |
| DGX | Buy | Quest Diagnostics Incorporated | $5,537,000 | +31.6% | 66,500 | +70.5% | 0.24% | +54.9% |
| STE | Buy | STERIS plcshares | $5,129,000 | +27.4% | 48,003 | +36.4% | 0.22% | +50.7% |
| XRAY | Buy | DENTSPLY SIRONA Inc. | $4,675,000 | +115.0% | 125,625 | +118.1% | 0.20% | +153.2% |
| IQV | Buy | IQVIA Holdings Inc. | $4,542,000 | +108.3% | 39,100 | +132.7% | 0.19% | +145.6% |
| ANAB | Buy | AnaptysBio, Inc. | $4,200,000 | -8.3% | 65,845 | +43.4% | 0.18% | +8.4% |
| ZGNX | Buy | Zogenix, Inc. | $4,048,000 | +23.3% | 111,025 | +67.8% | 0.17% | +45.4% |
| ABMD | Buy | ABIOMED, Inc. | $4,014,000 | +137.9% | 12,350 | +229.3% | 0.17% | +182.0% |
| LH | Buy | Laboratory Corporation of America Holdingssponsored adr | $3,677,000 | +73.5% | 29,100 | +138.5% | 0.16% | +103.9% |
| LGND | Buy | Ligand Pharmaceuticals Incorporated | $3,589,000 | +46.3% | 26,450 | +195.9% | 0.15% | +73.0% |
| WCG | New | WellCare Health Plans, Inc. | $3,069,000 | – | 13,000 | +100.0% | 0.13% | – |
| PHG | Buy | Koninklijke Philips N.V.ny reg sh | $2,998,000 | +99.1% | 85,400 | +158.0% | 0.13% | +132.7% |
| CHRS | Buy | Coherus Biosciences, Inc. | $2,852,000 | +15.4% | 315,162 | +110.4% | 0.12% | +35.6% |
| SGMO | Buy | Sangamo Therapeutics, Inc. | $2,773,000 | -4.8% | 241,538 | +40.5% | 0.12% | +12.3% |
| PTCT | Buy | PTC Therapeutics, Inc. | $2,356,000 | +3.6% | 68,652 | +41.9% | 0.10% | +23.2% |
| AGIO | Buy | Agios Pharmaceuticals, Inc. | $2,261,000 | -13.4% | 49,025 | +44.7% | 0.10% | +2.1% |
| MRNS | Buy | Marinus Pharmaceuticals, Inc. | $2,169,000 | -35.5% | 755,776 | +124.8% | 0.09% | -23.8% |
| NTLA | Buy | Intellia Therapeutics, Inc. | $2,051,000 | +4.4% | 150,290 | +118.9% | 0.09% | +23.9% |
| XNCR | New | Xencor, Inc. | $2,031,000 | – | 56,172 | +100.0% | 0.09% | – |
| INGN | New | Inogen, Inc. | $1,676,000 | – | 13,500 | +100.0% | 0.07% | – |
| NUVA | Buy | NuVasive, Inc. | $1,428,000 | +2.7% | 28,816 | +47.2% | 0.06% | +22.0% |
| RDY | New | Dr. Reddy's Laboratories Limited | $1,376,000 | – | 36,500 | +100.0% | 0.06% | – |
| ICPT | New | Intercept Pharmaceuticals, Inc. | $1,345,000 | – | 13,348 | +100.0% | 0.06% | – |
| ITCI | Buy | Intra-Cellular Therapies, Inc. | $1,255,000 | +66.0% | 110,193 | +216.2% | 0.05% | +100.0% |
| BOLD | Buy | Audentes Therapeutics, Inc. | $1,121,000 | -26.9% | 52,574 | +35.7% | 0.05% | -14.3% |
| LIVN | Buy | LivaNova plcshares | $1,043,000 | +33.9% | 11,400 | +81.3% | 0.04% | +60.7% |
| NVCR | New | Novocure Limitedordinary shares | $820,000 | – | 24,500 | +100.0% | 0.04% | – |
| New | Takeda Pharmaceutical Co. Ltd.sponsored ads | $649,000 | – | 19,200 | +100.0% | 0.03% | – | |
| VKTX | New | Viking Therapeutics, Inc. | $436,000 | – | 57,008 | +100.0% | 0.02% | – |
| ARWR | New | Arrowhead Pharmaceuticals, Inc. | $381,000 | – | 30,700 | +100.0% | 0.02% | – |
| CLSD | Buy | Clearside Biomedical, Inc. | $177,000 | -65.2% | 165,330 | +100.0% | 0.01% | -55.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.